Heidelberg Pharma AG (ETR:HPHA)

BRIEF

published on 12/17/2025 at 09:26, 1 day 10 hours ago

Heidelberg Pharma confrontée à des difficultés financières dans un contexte d'ajustements stratégiques

Essais Cliniques Réduction Des Coûts Heidelberg Pharma Défis Financiers Recherche Sur Le Cancer
BRIEF

published on 12/17/2025 at 09:26, 1 day 10 hours ago

Heidelberg Pharma Faces Financial Hurdles Amid Strategic Adjustments

Clinical Trials Cancer Research Cost-cutting Heidelberg Pharma Financial Challenges
PRESS RELEASE

published on 12/17/2025 at 09:21, 1 day 11 hours ago

Heidelberg Pharma: Letter from the CEO
Heidelberg Pharma CEO addresses delays in milestone payment, emphasizing continued development of TLX250-CDx and promising phase I study results for pamlectabart tismanitin (HDP-101). Financial challenges are being addressed proactively

CEO Heidelberg Pharma Milestone Payment TLX250-CDx Pamlectabart Tismanitin
BRIEF

published on 11/24/2025 at 18:03, 24 days 2 hours ago

Heidelberg Pharma nomme le Dr Liu au poste de PDG dans un contexte de changements au sein de sa direction.

Heidelberg Pharma Industrie Biotechnologique CAN Changement Exécutif Dr Jeffery Liu
BRIEF

published on 11/24/2025 at 18:03, 24 days 2 hours ago

Heidelberg Pharma Appoints Dr. Liu as CEO Amid Management Changes

Biotech Industry Heidelberg Pharma ADCs Executive Change Dr. Jeffery Liu
PRESS RELEASE

published on 11/24/2025 at 17:58, 24 days 2 hours ago

Heidelberg Pharma Announces Changes to the Executive Management Board – Dr Dongzhou Jeffery Liu Appointed as Chairman of the Executive Board and Chief Executive Officer
Heidelberg Pharma appoints Dr. Dongzhou Jeffery Liu as Chairman and CEO, replacing Prof. Andreas Pahl. The biotech company focuses on ADC technology for cancer treatment

Cancer Treatment Heidelberg Pharma ADC Technology Executive Management Board Dongzhou Jeffery Liu
BRIEF

published on 11/24/2025 at 15:09, 24 days 5 hours ago

Heidelberg Pharma nomme un nouveau PDG dans un contexte de changements au sein de sa direction

Heidelberg Pharma Industrie Biotechnologique Changements Exécutifs Dr Dongzhou Liu CAN
BRIEF

published on 11/24/2025 at 15:09, 24 days 5 hours ago

Heidelberg Pharma Appoints New CEO Amidst Executive Changes

Executive Changes Biotech Industry Heidelberg Pharma ADCs Dr. Dongzhou Liu
PRESS RELEASE

published on 11/24/2025 at 15:04, 24 days 5 hours ago

EQS-Adhoc: Heidelberg Pharma Announces Changes to the Executive Management Board - Dr Dongzhou Jeffery Liu Appointed as Chairman of the Executive Board and Chief Executive Officer
Heidelberg Pharma AG announces changes to the Executive Management Board - Dr. Dongzhou Jeffery Liu appointed as Chairman of the Executive Board and Chief Executive Officer

Chairman CEO Heidelberg Pharma AG Executive Management Board Dr. Dongzhou Jeffery Liu
BRIEF

published on 11/06/2025 at 07:14, 1 month 12 days ago

Heidelberg Pharma's HDP-101 Advances in Multiple Myeloma Trial

Clinical Trial Heidelberg Pharma HDP-101 Multiple Myeloma ATAC Technology

Published on 12/18/2025 at 18:00, 2 hours 25 minutes ago

PPX Mining Announces 2025 AGM Results
Published on 12/18/2025 at 15:00, 5 hours 25 minutes ago

Vox Royalty Acquires Feasibilty-Stage Stockman Copper-Gold Royalty in Australia
Published on 12/18/2025 at 14:31, 5 hours 54 minutes ago

Worksport Reports Highest Monthly Revenue in Company History
Published on 12/18/2025 at 14:00, 6 hours 25 minutes ago

Route1 Announces Provisional Patent Application
Published on 12/18/2025 at 14:00, 6 hours 25 minutes ago

LQR House Announces $6.52 Million Registered Direct Offering

View all ACCESSWIRE

Published on 12/18/2025 at 20:09, 16 minutes ago

EQS-Adhoc: The Grounds Real Estate Development AG: Conversion of the EUR 17 million bond issued in 2023/2024 into a hybrid bond
Published on 12/18/2025 at 19:30, 55 minutes ago

Prodware: COMMUNIQUE DU 18 DECEMBRE 2025 RELATIF A LA MISE A DISPOSITION DE LA NOTE EN REPONSE ET DES INFORMATIONS RELATIVES AUX CARACTERISTIQUES DANS LE CADRE DE L’OFFRE PUBLIQUE DE RETRAIT
Published on 12/18/2025 at 19:30, 55 minutes ago

Prodware: COMMUNIQUE DU 18 DECEMBRE 2025 RELATIF A LA MISE A DISPOSITION DE LA NOTE D’INFORMATION ET DES INFORMATIONS RELATIVES AUX CARACTERISTIQUES , NOTAMMENT JURIDIQUES, FINANCIERE DE PHAST INVEST
Published on 12/18/2025 at 18:48, 1 hour 37 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 12/18/2025 at 18:45, 1 hour 39 minutes ago

PATRIMOINE ET COMMERCE: PROJET D’AUGMENTATIONS DE CAPITAL DE PATRIMOINE & COMMERCE D’UN MONTANT DE 30 MILLIONS D’EUROS

View all EQS

Published on 12/18/2025 at 18:30, 1 hour 55 minutes ago

Schneider Electric completes transaction to acquire remaining 35% stake in existing Indian JV
Published on 12/18/2025 at 18:30, 1 hour 55 minutes ago

Schneider Electric finalise l’opération d’acquisition des 35% restants du capital de sa JV existante en Inde
Published on 12/18/2025 at 17:45, 2 hours 40 minutes ago

Cie du Bois Sauvage: Vernietiging eigen aandelen
Published on 12/18/2025 at 17:45, 2 hours 40 minutes ago

Damartex réaffirme son éligibilité au PEA-PME
Published on 12/18/2025 at 17:45, 2 hours 40 minutes ago

Cie du Bois Sauvage : Cancellation of own shares

View all LES ECHOS COMFI WIRE

News